Combination microdrops for ROP screening: Fewer systemic adverse events than standard mydriatrics
January 6th 2025The rationale was that commercial mydriatics administered during retinopathy of prematurity (ROP) screening have been associated with cardiorespiratory and gastrointestinal adverse events.
Research team identifies barriers to annual diabetic retinopathy screening
January 6th 2025After reviewing information collected on a patient database, the team suggested telephone prompts for patients with mental health concerns, text message reminders, and online educational tools to improve uptake to increase eye screening attendance.